June 27- July 1, 2015 London
2-P | STEPWISE QUALITY IMPROVEMENT IN A SMALL SCALE CARIBBEAN BLOOD BANK LONG TERM SUCCESS OF PROCESS APPROACH | Willem Smid | Received |
11-P | RISK-BASED DECISION-MAKING FOR BLOOD SAFETY | Connor Hubbard-MacLeod | Received |
17-P | THE USE OF CELLULAR AND TABLET DEVICES AS A TEACHING AND INFORMATION RESOURCE TOOL | Jerry Squires | Received |
18-P | STANDARDIZED 2D LABEL DESIGN FOR BLOOD PRODUCTS | Ruth Miller | Received |
30-P | BLOOD UTILIZATION IN ELECTIVE SURGERY IN A TERTIARY CENTER IN LAGOS, NIGERIA | sarah john-olabode | Received |
33-P | BLENDED LEARNING MODEL FOR REGULATED TRAINING IN A BLOOD CENTER | Paula Howard | Received |
60-P | PATIENT BLOOD MANAGEMENT ORGANISATION AND ACTIVITIES IN SEVEN EUROPEAN UNIVERSITY HOSPITALS | Kate Pendry | Received |
62-P | WHERE DID THE BLOOD GO?BLOOD USE AT THE UNIVERSITY HOSPITAL OF COLOGNE | Laura Behrens | Received |
76-P | LARGE SUSTAINED REDUCTION IN THE TRANSFUSION OF FRESH FROZEN PLASMA AFTER ESTABLISHMENT OF A CULTURE CHANGE | Joseph Sweeney | Received |
85-P | IMPROVING (AND MEASURING) BLOOD TRACEABILITY, PRODUCTION PROCESS CONTROL AND EFFICIENCY WITH RFID-BASED SOLUTION RHESUS AT SEVILLES REGIONAL TRANSFUSION CENTRE | Juan Pedro Benitez | Received |
96-P | TRANSFUSION KEY PERFORMANCE INDICATORS - ONE YEARS EXPERIENCE | Julie Johnson | Received |
102-P | CHALLENGES IN CHANGE CONTROL IN BLOOD ESTABLISHMENTS (BE) - HOW AND WHEN CORRECTLY CHANGE LOCATION OF BLOOD SEPARATORS IN USE AND VALIDATE NEW SEPARATORS AT THE SAME TIME | Zoran Bolta | Received |
113-P | GENETIC FACTORS ASSOCIATED WITH FERRITIN LEVELS: A STUDY IN THE AUSTRALIAN DONOR POPULATION | Helen Faddy | Received |
115-P | WHY ARE YOU NOT DONATING FOR VNRBD? A DESCRIPTION OF REASONS | Tanya Christiansen | Received |
128-P | DONOR EXPECTATIONS AND COUNSELLING IN KUMASI, GHANA | Veena Sharma | Received |
132-P | VOLUNTARY AND DIRECTED BLOOD DONORS PROBLEMS AND ATTITUDE | SONIA SHORMIN MIAH | Received |
137-P | GIVE BLOOD FOR THE FIRST TIME AND FOREVER. THE NEW PROMOTION CAMPAIGN BY AVIS, THE ITALIAN VOLUNTEER BLOOD DONORS ASSOCIATION | Boris Zuccon | Received |
147-P | DISTANCE TO THE BLOOD BANK MATTERS | Tanya Christiansen | Received |
162-P | WHEN WOULD YOU PREFER TO DONATE BLOOD? | Tanya Christiansen | Received |
167-P | A PROSPECTIVE ANALYSIS OF THE PRODUCTIVITY OF MCS UPP-999 (HAEMONETICS) AND AMICUS 3.21 (FRESENIUS KABI) IN 222 APHERESIS DONORS | Angel Luis Pajares Herraiz | Received |
168-P | POST DONATION INFORMATION: IS IT USEFUL, IS IT TIMELY? | Susan Barnes | Received |
169-P | EFFECTS OF OPTIA RED CELL EXCHANGE TRANSFUSION IN SICKLE CELL DISEASE ON BLOOD PARAMETERS ASSOCIATED WITH BLEEDING RISK | Gavin Cho | Received |
175-P | INFLUENCE OF APHERESIS INLET BLOOD FLOW ON THE QUALITY PRODUCT OF HAEMATOPOIETIC PROGENITOR STEM CELLS COLLECTION | EVA ALONSO | Received |
177-P | PLATELETAPHERESIS IN NIGERIA: THE UNIVERSITY OF BENIN TEACHING HOSPITAL, BENIN CITY EXPERIENCE | Benedict Nwogoh | Received |
198-P | PREVENTION OF FAINTING REACTIONS AFTER WHOLE BLOOD DONATION: A CLUSTER RANDOMIZED TRIAL TO ASSESS THE EFFICACY OF HYDRATION WITH ISOTONIC SOLUTION, WATER AND APPLIED MUSCLE TENSION | Chrystelle Morand | Received |
223-P | EFFECTS OF SUPER-COOLING BY MEANS OF MAGNETISM ON CRYOPRESERVATION OF BLOOD PRODUCTS IN VITRO | Geir Hetland | Received |
231-P | EVALUATION OF THE TPL IMUFLEX CRC SET INCLUDING THE NEW SEPACELLTM R-S01 LEUKOREDUCTION FILTER FOR RED BLOOD CELL UNITS | Melanie Stoermer | Received |
232-P | HEMOLYSIS IN IN-DATE RED CELL CONCENTRATES | Joseph Sweeney | Received |
238-P | STATUS OF ADDITIVE SOLUTION 7 | John Hess | Received |
242-P | THE UK NATIONAL FROZEN BLOOD BANK : A FIVE YEAR REVIEW OF PROVISION OF RARE PHENOTYPED UNITS | Gina MacLaren | Received |
259-P | RATE OF PLATELET BACTERIAL CONTAMINATION IN UGANDA | Aaron Tobian | Received |
267-P | THROMBOLUX EVALUATION OF PLATELET QUALITY AND BACTERIAL CONTAMINATION IN BUFFY COAT PLATELET CONCENTRATES | Annette Vetlesen | Received |
272-P | PREPARATION OF THAWED WASHED RED CELLS SUITABLE FOR INTRA-UTERINE (IUT) AND NEONATAL TOP-UP TRANSFUSION | Gina MacLaren | Received |
283-P | PREPARATION OF POOLED PLATELETS IN ADDITIVE SOLUTION | Zharas Bibekov | Received |
287-P | IDENTIFYING MAJOR DONOR AND PROCESS PARAMETERS ON FVIII AND FIBRINOGEN CONTENT OF FFP24 | Stéphane Bégué | Received |
294-P | THE ASSESSMENT OF PLATELET FUNCTION BY THROMBELASTOGRAPHY AFTER TRANSFUSION OF INTERCEPT TREATED PLATELETS REVEALS SATISFYING RESULTS. | Gerda Leitner | Received |
300-P | CHIKUNGUNYA AND ROSS RIVER VIRUSES ARE EFFECTIVELY INACTIVATED BY THE THERAFLEX UV-PLATELETS TECHNOLOGY | Denese Marks | Received |
302-P | PARVOVIRUS B19 TRANSMISSION BY TRANSFUSION OF INTERCEPT BLOOD SYSTEM-TREATED THROMBOCYTE CONCENTRATE | Christoph Niederhauser | Received |
310-P | RFID TAGS ROBUSTNESS AND TRACEABILITY IN THE PROCESS OF METHYLENE BLUE TREATED PLASMA | Nicolas de Valensart | Received |
315-P | REDUCTION OF FEBRILE AND ALLERGIC REACTIONS IN PATIENTS RECEIVING PLATELETS TREATED WITH RIBOFLAVIN AND UV LIGHT | Teresa Jimenez-Marco | Received |
322-P | VALIDATION OF DOUBLE DOSE BUFFY-COAT PLATELET PROCESSING USING THE INTERCEPT DUAL STORAGE PROCESSING SET PREPARED FROM SEVEN BUFFY-COATS | Angel Luis Pajares Herraiz | Received |
325-P | STABILITY AND INTER-DONOR VARIABILITY OF SERUM GROWTH FACTORS STORED IN DIFFERENT SERUM EYE DROP PACKAGING SYSTEMS | Denese Marks | Received |
328-P | LYSATES PRODUCED FROM IRRADIATED AND EXPIRED BUFFY COAT-DERIVED PLATELETS STORED IN ADDITIVE SOLUTION SUPPORT CELL PROLIFERATION | Yen Siew Loh | Received |
329-P | DYNAMIC LIGHT SCATTERING AS A TOOL FOR THE ANALYSIS OF PLATELET QUALITY FOLLOWING CRYOPRESERVATION | Lacey Johnson | Received |
336-P | COMPARISON OF THE PREVALENCE OF INFECTIOUS AGENTS IN ENGLISH BLOOD AND DECEASED TISSUE DONORS | Kitchen Alan | Received |
337-P | THIRTEEN YEARS OF NAT SCREENING IN BLOOD DONORS: NEW INSIGHTS ON HIV, HCV AND HBV INCIDENT CASES, THE FRENCH EXPERIENCE | Syria LAPERCHE | Received |
340-P | THE IMPORTANCE OF CONFIRMATORY TESTING OF DONATIONS THAT ARE REACTIVE ON INFECTIOUS DISEASE SCREENING | Ania Zuczkowska | Received |
342-P | HOW DO WE RESPOND TO NEW KNOWLEDGE CONCERNING HEV RNA PREVALENCE IN GERMAN BLOOD DONOR BASE AND THE RISK OF TRANSMISSION TO IMMUNCOMPROMISED RECIPIENTS? ? HEV NAT-TESTING FOR THROMBAPHERESIS AND SDR DONATIONS | Christine Scheuch | Received |
346-P | PERFORMANCE CHARACTERISTICS OF A TRANSCRIPTION-MEDIATED AMPLIFICATION ASSAY FOR PARVOVIRUS B19 AND HEPATITIS A VIRUS ON A FULLY AUTOMATED SYSTEM | Edgar Ong | Received |
354-P | IMPLEMENTATION OF THE NEW COBAS 6800/COBAS P 680 AND COBAS MPX FOR NAT SCREENING OF BLOOD DONATIONS: A SAFETY AND EFFICIENCY TOOL | LUISA BAREA | Received |
356-P | VALIDATION OF THE COBAS MPX TEST ON THE COBAS 8800 SYSTEM IN A ROUTINE BLOOD TRANSFUSION SCREENING LABORATORY | Martin Stolz | Received |
358-P | EVALUATION OF THE PROCLEIX ULTRIO ELITE ASSAY (GRIFOLS) FOR NAT HIV-1/2, HCV AND HBV SCREENING ON BLOOD DONORS AND ON CELL AND TISSUE BANK SPECIMENS | Rodenbach Marie-Pierre | Received |
383-P | COMPARISON OF DIFFERENT TECHNIQUES USED IN A TRANSFUSION TRANSMITTED INFECTION LABORATORY IN THE BLOOD BANK | SUDHA Ranganathan | Received |
392-P | NUCLEIC ACID AMPLIFICATION TEST(NAT) TO DETECT HBV INFECTION IN BLOOD DONORS | Surekha Devi Allanki | Received |
394-P | APPARENT DISCREPANCY BETWEEN THE VIRUS CONCENTRATIONS IN THE 2ND AND 4TH WHO INTERNATIONAL HCV STANDARDS | Peter Gowland | Received |
407-PA | ANALYSIS OF HIV-1 SUBTYPES AMONG HIV-POSITIVE BLOOD DONORS IN CATALONIA (SPAIN) | Marta Bes | Received |
422-P | INSIGHTS INTO BACTERIAL SURVIVAL AND DISTRIBUTION DURING BUFFY COAT PLATELET PRODUCTION | Sandra Ramirez | Received |
430-P | PERFORMANCE OF A NEW AUTOMATED SYPHILIS ASSAY FOR THE DETECTION OF THE PRESENCE OF ANTIBODIES TO TREPONEMA PALLIDIUM | George Schlauder | Received |
436-P | SURVEY FOR BACTERIAL TESTING IN PLATELET CONCENTRATES IN LATIN AMERICA | Sandra Ramirez | Received |
439-P | MALARIA AND T.CRUZI SCREENING IN UK DECEASED ORGAN DONORS | Mhairi Webster | Received |
442-P | EVALUATION OF NOVALISA MALARIA MALARIA AB ASSAY | Kitchen Alan | Received |
444-P | PLATELET CONCENTRATES: HIGH-RISK BLOOD COMPONENTS IN THE TRANSFUSION- TRANSMISSION OF TRYPANOSOMA CRUZI IN NON- ENDEMIC CHAGAS DISEASE AREAS. | Beatriz Cancino-Faure | Received |
454-P | PERFORMANCE CHARACTERISTICS OF A TMA ASSAY FOR DENGUE VIRUS DETECTION ON A FULLY AUTOMATED PLATFORM AND EVALUATION OF THE IMPACT OF POOLING USING BLOOD DONATIONS FROM PUERTO RICO | Vanessa Bres | Received |
455-P | TRANSFUSION TRANSMITTED ANAPLASMOSIS FROM POOLED PLATELETS | Joseph Sweeney | Received |
459-P | COMPARISON OF TWO COMMERCIAL HEPATITIS E VIRUS ELISA KITS IN AUSTRALIAN BLOOD DONOR SAMPLES | Helen Faddy | Received |
460-P | HEPATITIS A VIRUS ANTIBODY LEVELS IN SEROPOSITIVE BLOOD DONORS | Helen Faddy | Received |
465-P | CONFIRMATION OF ANTI-HTLV SCREEN REACTIVITY | Kitchen Alan | Received |
478-P | TRANSFUSION SUPPORT AND MANAGEMENT FOR A PREGNANT THALASSAEMIA INTERMEDIA PATIENT WITH ANTI-Jra | Nay Win | Received |
484-P | FURTHER EVIDENCE FOR THE CLINICAL SIGNIFICANCE OF ANTI-JRA | MALCOLM NEEDS | Received |
498-P | INTRODUCTION OF AN ADDITIONAL RED CELL ANTIBODY SCREENING TEST AT 36 WEEKS IN PREGNANT WOMEN RECEIVING ROUTINE ANTENATAL ANTI-D (RAADP) AT 28-30 WEEKS OF PREGNANCY | Kati Sulin | Received |
499-P | POTENTIAL INTERFERENCE OF DARATUMUMAB IN ROUTINE BLOOD TRANSFUSION POLICIES AND SEROLOGICAL TESTS | EVA ALONSO | Received |
524-P | RECOMBINANT GROUP PROTEINS PROVED TO BE A HELPFUL TOOL FOR ANTIBODY SCREENING IN PRESENCE OF AN ANTI-KN(A) | Christof Weinstock | Received |
525-P | A CASE: RHD ALLOIMMUNIZATION AFTER TRANSFUSION OF ONE UNIT OF APHERESIS PLATELETS | Yanhua Li | Received |
530-P | HIGH FIDELITY ANTIBODY IMMOBILIZED MICROBEAD TECHNOLOGY FOR BLOOD TYPING | kazumi kawakami | Received |
574-P | GENOTYPING TO REDUCE ANTI-D IMMUNOGLOBULIN USAGE IN A DIVERSE POPULATION DEMOGRAPHIC: FETAL RHD DETECTION FOR MOTHERS HARBOURING RHD VARIANTS | Robert Flower | Received |
578-P | A PATIENT OF CAUCASIAN ORIGIN WITH AN APPARENT FY(A-B-) PHENOTYPE | Christine Henny | Received |
608-P | HIGH-THROUGHPUT PERFORMANCE TESTING OF A FOCUSED BLOOD GROUP GENOTYPING PANEL IN A LARGE COHORT OF DNA SAMPLES | Anders Nygren | Received |
611-P | A MISSING RHD-CE-D HYBRID IN AN RHD POSITIVE BLOOD DONOR: IMPLICATIONS FOR FUTURE BLOOD GROUP INTERPRETATIVE ALGORITHMS | Robert Flower | Received |
622-P | ROUTINE COMPLEMENTARY MOLECULAR AND SEROLOGIC ANTIGEN DETERMINATION IN A EUROPEAN, MAINLY HEMATOLOGIC PATIENT POPULATION | Franz Wagner | Received |
628-P | A NOVEL SSO GENOTYPING METHOD FOR BLOOD GROUP ALLELES ON MR.SPOT SYSTEM | Marina Albrizio | Received |
636-P | NEW INSIGHTS INTO THE GENDER DIFFERENCES IN HEMOLYSIS: EFFECT OF TESTOSTERONE AND MAPK-MEDIATED HEMOLYSIS IN MICE | Tamir Kanias | Received |
651-P | DIAGNOSTIC POTENTIAL OF MULTIPLE ASSAYS OF ANTI-HPA-1A FOR PREDICTION OF FETAL THROMBOCYTOPENIA IN HPA-1A ALLOIMMUNISED WOMEN | Belinda Kumpel | Received |
678-P | SUCCESSFUL MANAGEMENT OF HAEMOLYTIC DISEASE OF THE FETUS AND NEWBORN DUE TO AN ANTI-RH17 ANTIBODY | Akila CHANDRASEKAR | Received |
686-P | ASSESSING FOR IMMUNODEFICIENCY AND THE NEED FOR IRRADIATED BLOOD PRODUCTS IN CHILDREN WITH SUSPECTED DIGEORGE SYNDROME UNDERGOING CARDIAC SURGERY A UK SURVEY | Sara Mele | Received |
687-P | INDICATIONS AND USE OF CRYOPRECIPITATE IN THE PEDIATRIC INTENSIVE CARE UNIT | Melissa Cushing | Received |
694-P | AUDIT OF PLASMA EXCHANGE FOR HYPERVISCOSITY AT NHSBT TAS OXFORD: THE CHANGING ROLE OF THERAPEUTIC APHERESIS | Elizabeth Marrinan | Received |
697-P | NHSBT NATIONAL THERAPEUTIC APHERESIS SERVICES STANDARDISED PRACTICE RESULTS IN EXCELLENT PATIENT OUTCOMES IN TTP | Sylvia Benjamin | Received |
714-P | RBC ANTIGEN PHENOTYPE MATCHED RED CELL TRANSFUSIONS FOR THALASSEMIA PATIENTS TO PREVENT ALLOIMMUNSATION : HOW MUCH IS ENOUGH? | PRITI ELHENCE | Received |
715-P | POST-TRANSFUSION HYPERHAEMOLYSIS SYNDROME (PTHS) IN SICKLE CELL DISEASE (SCD): AN AUTOPSY FINDINGS SUPPORTING MACROPHAGE ACTIVATION | Nay Win | Received |
716-P | PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA IN SOUTH-EAST NORWAY 2000-2010 HISTORY, DIAGNOSTICS AND TREATMENT | Lise Sofie H. Nissen-Meyer | Received |
719-P | USE OF MANUAL AND ELECTRONIC INFUSION DEVICES TO RED BLOOD CELLS TRANSFUSION: SEEKING EVIDENCES FOR NURSING PRACTICE | Mavilde Pedreira | Received |
724-P | SUCCESS OF PBM IN JAPAN SUPPORTED BY FEES FOR SERVICE | Shoichi Inaba | Received |
727-P | FOUR YEARS OF TAILORED LOW DOSE PROPHYLAXIS IN A SMALL COHORT OF KIDS WITH SEVERE HEMOPHILIA A USING SD-F CRYOPRECIPITATE | Ahmed El Ekiaby | Received |
730-P | THE DEVELOPMENT OF A BIG TRANSFUSION DATASET IN A LARGE TEACHING HOSPITAL | Kate Pendry | Received |
758-P | MANAGEMENT OF WARFARIN-ASSOCIATED COAGULOPATHY (WAC) IN PATIENTS WITH ACUTE GASTROINTESTINAL BLEEDING (GIB) | Jaroslava Andreeva | Received |
768-P | NOTIFY LIBRARY OF ADVERSE OUTCOMES FROM MEDICAL PRODUCTS OF HUMAN ORIGIN EXPANDS TO INCLUDE BLOOD | Barbee Whitaker | Received |
772-P | TRALI: ASSOCIATED WITH DONOR PRIMARY AUTOIMMUNE NEUTROPENIA | Nuala Moore | Received |
782-P | SHOULD WE TRANSFUSE AT NIGHT? | Rebecca Patel | Received |
786-P | IGA DEFICIENCY AND TRANSFUSION REACTIONS: A CASE REPORT ILLUSTRATING CURRENT PATIENT MANAGEMENT | Kathryn Musgrave | Received |
790-P | VALIDATION OF A TRANSFUSION SAFETY SYSTEM BASED ON RFID TECHNOLOGY | Anna Millan | Received |
792-P | HAEMOVIGIL: A NOVEL SYSTEM TO PREVENT BEDSIDE PHLEBOTOMY AND TRANSFUSION ERRORS DUE TO PATIENT MIS-IDENTIFICATION | Gautam Wankhede | Received |
804-P | PATIENT CHARACTERISTICS AND RATE OF ACUTE TRANSFUSION REACTIONS TO PLATELET TRANSFUSIONS IN UGANDA | Aaron Tobian | Received |
820-P | QUALITY OF CRYOPRESERVED CORD BLOOD UNITS IN THE PUBLIC CORD BLOOD BANK OF KOREA | Hye Ryun Lee | Received |
827-P | FLOW CYTOMETRY ANNEXIN V AND 7AAD FOR ASSESSMENT OF GRAFT QUALITY IN ALLOGENEIC HSC TRANSPLANTATION | Emma Watz | Received |
834-P | IMPACT OF ABO-BLOOD GROUP INCOMPATIBILITY ON TRANSFUSION OUTCOME AND SURVIVAL OF PATIENTS UNDERGOING SINGLE-UNIT UMBILICAL CORD BLOOD TRANSPLANTATION: EXPERIENCE OF A SINGLE INSTITUTION | Pilar Solves | Received |
837-P | ALLELIC TYPING OF KIR2DL1 AND KIR3DL1 GENES TO DEFINE LOW/HIGH AFFINITY RECEPTOR-LIGAND COMBINATIONS AND IMPROVE DONOR SELECTION IN STEM CELL TRANSPLANTATION | Christian Seidl | Received |
June 27- July 1, 2015 London
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|